P2P review overturns denials about 35-45% of the time when the prescriber comes prepared with chart data and trial evidence
Clinical Trial Findings on Heart Rate Several clinical trials have monitored heart rate changes in patients taking tirzepatide
Diabetes or metabolic syndromes: People living with diabetes or metabolic syndromes, such as high blood pressure, high blood sugar, excess body fat around the waist, and irregular cholesterol levels, may also experience inflammation in the body, which can impact the health of the shoulder and rotator cuff, particularly leading to adhesive capsulitis (frozen shoulder)
Side Effects Comparison# Retatrutide Side Effects# Phase 2 trial data revealed: Gastrointestinal : Nausea (24-46%), diarrhea (16-26%), vomiting (9-20%), constipation (6-16%) Heart rate : Small mean increase (2-4 bpm) potentially related to glucagon receptor activation Injection site reactions : Mild and transient Hepatic : Transient elevations in liver enzymes observed Discontinuation rate : 6-10% due to adverse events in Phase 2 The glucagon receptor component introduces a unique side effect profile compared to GLP-1-only or GIP/GLP-1 dual agonists